Preview: Twist Bioscience's Earnings
Twist Bioscience (NASDAQ:TWST) is preparing to release its quarterly earnings on Monday, 2025-08-04. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Twist Bioscience to report an earnings per share (EPS) of $-0.56.
The market awaits Twist Bioscience's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Historical Earnings Performance
During the last quarter, the company reported an EPS missed by $0.10, leading to a 8.85% drop in the share price on the subsequent day.
Here's a look at Twist Bioscience's past performance and the resulting price change:
| Quarter | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.56 | -0.63 | -0.69 | -0.77 |
| EPS Actual | -0.66 | -0.53 | -0.59 | -0.70 |
| Price Change % | -9.0% | -1.0% | -0.0% | -19.0% |
Stock Performance
Shares of Twist Bioscience were trading at $33.57 as of July 31. Over the last 52-week period, shares are down 25.99%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
To track all earnings releases for Twist Bioscience visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkWebull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
English